课题基金 / 基金详情

Application of direct reprogramming technology for the treatment of hereditary rare liver diseases

Application of direct reprogramming technology for the treatment of hereditary rare liver diseases
直接重编程技术在遗传性罕见肝病治疗中的应用
批准号:
21K19916
负责人:
Suzuki Atsushi
金额:
$4.16万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
财政年份:
2021
资助国家:
日本
项目状态:
已结题
起止时间:
2021-07-09 至 2023-03-31

项目摘要

项目成果

Suzuki Atsushi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of the Clk2 kinase pathway in neural development and the etiology of autism
  • 批准号:
    20K07225
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2020
  • 负责人:
    Suzuki Atsushi
  • 依托单位:
Establishment and application of the method for inducing human hepatic progenitor cells by direct reprogramming
  • 批准号:
    19H01177
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 资助金额:
    $29.12万
  • 财政年份:
    2019
  • 负责人:
    Suzuki Atsushi
  • 依托单位:
Method for Planning and Evaluating Residential Complex Revitalization Considering the Interrelation among QOL Components and Household Transitions
  • 批准号:
    18K04399
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2018
  • 负责人:
    Suzuki Atsushi
  • 依托单位:
Application of X-ray computed tomography on coral skeletal climatology
海外基金